Cargando…
MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia
In 11q23 leukemias, the N-terminal part of the mixed lineage leukemia (MLL) gene is fused to >60 different partner genes. In order to define a core set of MLL rearranged targets, we investigated the genome-wide binding of the MLL-AF9 and MLL-AF4 fusion proteins and associated epigenetic signature...
Autores principales: | Prange, K H M, Mandoli, A, Kuznetsova, T, Wang, S-Y, Sotoca, A M, Marneth, A E, van der Reijden, B A, Stunnenberg, H G, Martens, J H A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474565/ https://www.ncbi.nlm.nih.gov/pubmed/28114278 http://dx.doi.org/10.1038/onc.2016.488 |
Ejemplares similares
-
Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9
por: Zhang, Li-shu, et al.
Publicado: (2018) -
Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair
por: Castaño, Julio, et al.
Publicado: (2016) -
The oncofusion protein FUS–ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia
por: Sotoca, A M, et al.
Publicado: (2016) -
MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors
por: Chen, Xinyue, et al.
Publicado: (2019) -
CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis
por: Sarrou, Evgenia, et al.
Publicado: (2020)